1 Study Coverage

• 1.1 Edaravone Product Introduction
• 1.2 Market Segments
• 1.3 Key Edaravone Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Edaravone Market Size Growth Rate by Type
  • 1.4.2 Oral
  • 1.4.3 Injection
• 1.5 Market by Application
  • 1.5.1 Global Edaravone Market Size Growth Rate by Application
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Edaravone Market Size, Estimates and Forecasts
  • 2.1.1 Global Edaravone Revenue 2015-2026
  • 2.1.2 Global Edaravone Sales 2015-2026
• 2.2 Global Edaravone, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Edaravone Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Edaravone Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Edaravone Competitor Landscape by Players

• 3.1 Edaravone Sales by Manufacturers
  • 3.1.1 Edaravone Sales by Manufacturers (2015-2020)
  • 3.1.2 Edaravone Sales Market Share by Manufacturers (2015-2020)
• 3.2 Edaravone Revenue by Manufacturers
  • 3.2.1 Edaravone Revenue by Manufacturers (2015-2020)
  • 3.2.2 Edaravone Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Edaravone Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Edaravone Revenue in 2019
  • 3.2.5 Global Edaravone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Edaravone Price by Manufacturers
• 3.4 Edaravone Manufacturing Base Distribution, Product Types
  • 3.4.1 Edaravone Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Edaravone Product Type
  • 3.4.3 Date of International Manufacturers Enter into Edaravone Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Edaravone Market Size by Type (2015-2020)
  • 4.1.1 Global Edaravone Sales by Type (2015-2020)
  • 4.1.2 Global Edaravone Revenue by Type (2015-2020)
  • 4.1.3 Edaravone Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Edaravone Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Edaravone Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Edaravone Revenue Forecast by Type (2021-2026)
  • 4.2.3 Edaravone Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Edaravone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Edaravone Market Size by Application (2015-2020)
  • 5.1.1 Global Edaravone Sales by Application (2015-2020)
  • 5.1.2 Global Edaravone Revenue by Application (2015-2020)
  • 5.1.3 Edaravone Price by Application (2015-2020)
• 5.2 Edaravone Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Edaravone Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Edaravone Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Edaravone Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Edaravone by Country
  • 6.1.1 North America Edaravone Sales by Country
  • 6.1.2 North America Edaravone Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Edaravone Market Facts & Figures by Type
• 6.3 North America Edaravone Market Facts & Figures by Application

7 Europe

• 7.1 Europe Edaravone by Country
  • 7.1.1 Europe Edaravone Sales by Country
  • 7.1.2 Europe Edaravone Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Edaravone Market Facts & Figures by Type
• 7.3 Europe Edaravone Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Edaravone by Region
  • 8.1.1 Asia Pacific Edaravone Sales by Region
  • 8.1.2 Asia Pacific Edaravone Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Edaravone Market Facts & Figures by Type
• 8.3 Asia Pacific Edaravone Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Edaravone by Country
  • 9.1.1 Latin America Edaravone Sales by Country
  • 9.1.2 Latin America Edaravone Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Edaravone Market Facts & Figures by Type
• 9.3 Central & South America Edaravone Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Edaravone by Country
  • 10.1.1 Middle East and Africa Edaravone Sales by Country
  • 10.1.2 Middle East and Africa Edaravone Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Edaravone Market Facts & Figures by Type
• 10.3 Middle East and Africa Edaravone Market Facts & Figures by Application

11 Company Profiles

• 11.1 Mitsubishi Tanabe Pharma
  • 11.1.1 Mitsubishi Tanabe Pharma Corporation Information
  • 11.1.2 Mitsubishi Tanabe Pharma Description and Business Overview
  • 11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Mitsubishi Tanabe Pharma Edaravone Products Offered
  • 11.1.5 Mitsubishi Tanabe Pharma Related Developments
• 11.2 Simcere
  • 11.2.1 Simcere Corporation Information
  • 11.2.2 Simcere Description and Business Overview
  • 11.2.3 Simcere Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Simcere Edaravone Products Offered
  • 11.2.5 Simcere Related Developments
• 11.3 Taj Pharmaceuticals Ltd.
  • 11.3.1 Taj Pharmaceuticals Ltd. Corporation Information
  • 11.3.2 Taj Pharmaceuticals Ltd. Description and Business Overview
  • 11.3.3 Taj Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Taj Pharmaceuticals Ltd. Edaravone Products Offered
  • 11.3.5 Taj Pharmaceuticals Ltd. Related Developments
• 11.4 Sun Pharmaceutical Industries Ltd.
  • 11.4.1 Sun Pharmaceutical Industries Ltd. Corporation Information
  • 11.4.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
  • 11.4.3 Sun Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Products Offered
  • 11.4.5 Sun Pharmaceutical Industries Ltd. Related Developments
• 11.5 Unichem Laboratories Ltd
  • 11.5.1 Unichem Laboratories Ltd Corporation Information
  • 11.5.2 Unichem Laboratories Ltd Description and Business Overview
  • 11.5.3 Unichem Laboratories Ltd Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Unichem Laboratories Ltd Edaravone Products Offered
  • 11.5.5 Unichem Laboratories Ltd Related Developments
• 11.6 UCB India Ltd
  • 11.6.1 UCB India Ltd Corporation Information
  • 11.6.2 UCB India Ltd Description and Business Overview
  • 11.6.3 UCB India Ltd Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 UCB India Ltd Edaravone Products Offered
  • 11.6.5 UCB India Ltd Related Developments
• 11.7 Piramal Healthcare
  • 11.7.1 Piramal Healthcare Corporation Information
  • 11.7.2 Piramal Healthcare Description and Business Overview
  • 11.7.3 Piramal Healthcare Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Piramal Healthcare Edaravone Products Offered
  • 11.7.5 Piramal Healthcare Related Developments
• 11.1 Mitsubishi Tanabe Pharma
  • 11.1.1 Mitsubishi Tanabe Pharma Corporation Information
  • 11.1.2 Mitsubishi Tanabe Pharma Description and Business Overview
  • 11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Mitsubishi Tanabe Pharma Edaravone Products Offered
  • 11.1.5 Mitsubishi Tanabe Pharma Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Edaravone Market Estimates and Projections by Region
  • 12.1.1 Global Edaravone Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Edaravone Revenue Forecast by Regions 2021-2026
• 12.2 North America Edaravone Market Size Forecast (2021-2026)
  • 12.2.1 North America: Edaravone Sales Forecast (2021-2026)
  • 12.2.2 North America: Edaravone Revenue Forecast (2021-2026)
  • 12.2.3 North America: Edaravone Market Size Forecast by Country (2021-2026)
• 12.3 Europe Edaravone Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Edaravone Sales Forecast (2021-2026)
  • 12.3.2 Europe: Edaravone Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Edaravone Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Edaravone Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Edaravone Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Edaravone Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Edaravone Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Edaravone Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Edaravone Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Edaravone Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Edaravone Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Edaravone Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Edaravone Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Edaravone Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Edaravone Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Edaravone Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Edaravone Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Edaravone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Edaravone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Edaravone market is segmented into
Oral
Injection

Segment by Application, the Edaravone market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Edaravone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Edaravone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Edaravone Market Share Analysis
Edaravone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Edaravone business, the date to enter into the Edaravone market, Edaravone product introduction, recent developments, etc.

The major vendors covered:
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
...